Antenatal Corticosteroid Therapy: Which Impact on Birth Parameters?
1 other identifier
observational
363
0 countries
N/A
Brief Summary
Use of antenatal corticosteroids therapy has increased since the 2000s. The benefits of such a therapy on premature newborns are scientifically and internationally recognized. Nevertheless, few studies have been conducted to investigate the impact of this antenatal corticosteroid therapy on full-term newborns (\> 36 weeks' gestation). The aim of this study is to compare the birth parameters of full-term newborns exposed or not to antenatal corticosteroid therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedFirst Submitted
Initial submission to the registry
July 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 25, 2022
CompletedFirst Posted
Study publicly available on registry
December 7, 2022
CompletedDecember 12, 2022
December 1, 2022
7 years
July 12, 2022
December 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate the impact of an antenatal corticosteroid therapy on head growth.
head circumference
Birth
Secondary Outcomes (7)
Evaluate the impact of an antenatal corticosteroid therapy on fetal weight
Birth
Evaluate the impact of an antenatal corticosteroid therapy on fetal growth
birth
Evaluate the impact of an antenatal corticosteroid therapy on neonatal adaptation : APGAR score for each patient
birth
Evaluate the impact of an antenatal corticosteroid therapy on risk of hypoglycemia : number of patients with neonatal hypoglycémia
first 5 days
Evaluate the impact of an antenatal corticosteroid therapy on risk of hypocalcemia : number of patients with hypoglycemia
first 5 days
- +2 more secondary outcomes
Study Arms (2)
exposed group (121 patients)
Extrated from the population of full-term newborns (\> 36 weeks of amenorrhea + 6 days) between 2014 and 2020 at the Regional Maternity Hospital of Nancy who received at least one course of betamethasone before 34 weeks of amenorrhea for a threat of preterm delivery. Exposure to an antenatal corticosteroid therapy was defined as the administration of at least one course of betamethasone (i.e. two doses of 12 mg, 24 hours apart). in intramuscular, before 34 weeks of amenorrhea, for a threat of premature delivery.
nonexposed group (242 patients)
came from the population of full-term newborns (\> 36 weeks of amenorrhea + 6 days) between 2014 and 2020 at the Regional Maternity Hospital of Nancy who who had not been exposed to antenatal steroid therapy. Two controls were selected for a case, appaired on the month and year of birth and on the sex of the case patient.
Interventions
Eligibility Criteria
All children included in the study were born at the Regional Maternity Hospital of Nancy between January 1, 2014 and December 31, 2020. One hundred and twenty-one of them were exposed during pregnancy to antenatal corticosteroids therapy and constitute the exposed arm, whereas 242 were not and constitute the non-exposed arm.
You may qualify if:
- all children exposed to an antenatal corticosteroid therapy before 34 weeks of amenorrhea because of a threat of premature delivery
- only full-term newborns
You may not qualify if:
- all children exposed to an antenatal corticosteroid therapy before 34 weeks of amenorrhea for other reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Best C, Hascoet JM, Jeanbert E, Morel O, Baumann C, Renard E. Impact of corticosteroid exposure on preterm labor in neonates eventually born at term. J Perinatol. 2024 Feb;44(2):195-202. doi: 10.1038/s41372-023-01831-0. Epub 2023 Dec 1.
PMID: 38040875DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
July 12, 2022
First Posted
December 7, 2022
Study Start
January 1, 2014
Primary Completion
December 31, 2020
Study Completion
November 25, 2022
Last Updated
December 12, 2022
Record last verified: 2022-12